Royce & Associates LP decreased its holdings in shares of Alpha Teknova, Inc. (NASDAQ:TKNO – Free Report) by 4.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,581,019 shares of the company’s stock after selling 80,376 shares during the quarter. Royce & Associates LP’s holdings in Alpha Teknova were worth $14,071,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. BlackRock Inc. purchased a new stake in Alpha Teknova in the second quarter valued at $4,997,000. Bank of America Corp DE purchased a new position in shares of Alpha Teknova during the 2nd quarter worth $1,453,000. Bank of New York Mellon Corp purchased a new position in shares of Alpha Teknova during the 2nd quarter worth $604,000. GSA Capital Partners LLP purchased a new position in shares of Alpha Teknova during the 2nd quarter worth $303,000. Finally, Deutsche Bank AG acquired a new stake in shares of Alpha Teknova during the 2nd quarter worth about $62,000. Institutional investors and hedge funds own 13.81% of the company’s stock.
Alpha Teknova Stock Down 5.4%
Shares of NASDAQ TKNO opened at $7.77 on Tuesday. The company has a quick ratio of 3.48, a current ratio of 3.56 and a debt-to-equity ratio of 0.22. The business’s 50 day moving average is $7.87 and its two-hundred day moving average is $5.14. Alpha Teknova, Inc. has a 52-week low of $1.91 and a 52-week high of $9.48. The firm has a market cap of $488.73 million, a price-to-earnings ratio of -26.79 and a beta of 0.96.
Analyst Upgrades and Downgrades
TKNO has been the topic of several research analyst reports. Wall Street Zen upgraded shares of Alpha Teknova from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Roth Capital started coverage on shares of Alpha Teknova in a research report on Wednesday, August 5th. They issued a “buy” rating and a $7.00 target price on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Alpha Teknova in a research note on Wednesday, November 4th. TD Cowen lifted their price target on shares of Alpha Teknova from $7.00 to $11.00 and gave the company a “buy” rating in a research report on Tuesday, October 13th. Finally, Jefferies Financial Group assumed coverage on shares of Alpha Teknova in a research note on Thursday, September 17th. They issued a “buy” rating and a $9.00 price target on the stock. Four research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $8.75.
Read Our Latest Report on Alpha Teknova
Alpha Teknova Company Profile
Alpha Teknova, Inc. develops and manufactures reagents used in life science research and the development and production of biopharmaceuticals and diagnostic products. Its offerings include cell culture media, buffers, molecular biology reagents, proteins and other laboratory materials. The company provides both catalog products and custom reagent development and manufacturing services. Its customers include biotechnology and pharmaceutical companies, diagnostic developers, academic institutions and research laboratories.
Recommended Stories
- Five stocks we like better than Alpha Teknova
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Want to see what other hedge funds are holding TKNO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alpha Teknova, Inc. (NASDAQ:TKNO – Free Report).
Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.
